(Q53013240)

10 May 2018

title

Predictability of vancomycin trough concentrations using seven approaches for estimating pharmacokinetic parameters. (English)

1 reference

10 May 2018

0 references

1 reference

John E Murphy

1

1 reference

10 May 2018

David E Gillespie

series ordinal

2

1 reference

10 May 2018

Carol V Bateman

series ordinal

3

1 reference

10 May 2018

publication date

1 December 2006

1 reference

10 May 2018

American Journal of Health-System Pharmacy

published in

1 reference

10 May 2018

volume

63

1 reference

10 May 2018

issue

23

1 reference

10 May 2018

page(s)

2365-2370

1 reference

10 May 2018

Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Why monitor peak vancomycin concentrations?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

TDM coupled with Bayesian forecasting should be considered an invaluable tool for optimizing vancomycin daily exposure in unstable critically ill patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Why monitor peak vancomycin concentrations?

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

A simplified dosing method for initiating vancomycin therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Pharmacokinetics of vancomycin in patients with various degrees of renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Evaluation of a Bayesian method for predicting vancomycin dosing.

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Vancomycin pharmacokinetics in patients with various degrees of renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Evaluation of three methods for determining initial vancomycin doses

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Prediction of creatinine clearance from serum creatinine

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Predicting creatinine clearance and renal drug clearance in obese patients from estimated fat-free body mass

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Vancomycin therapeutic drug monitoring: is there a consensus view? The results of a UK National External Quality Assessment Scheme (UK NEQAS) for Antibiotic Assays questionnaire

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Guidelines for the Management of Adults with Hospital-acquired, Ventilator-associated, and Healthcare-associated Pneumonia

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Simulation of vancomycin peak and trough concentrations using five dosing methods in 37 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

Comparing two predictive methods for determining serum vancomycin concentrations at a Veterans Affairs Medical Center

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP060047

31 March 2020

Identifiers

DOI

10.2146/AJHP060047

1 reference

10 May 2018

1 reference

10 May 2018